Dance movement therapy for neurodegenerative diseases: A systematic review DOI Creative Commons
Cheng-Cheng Wu,

Huan-Yu Xiong,

Jiejiao Zheng

et al.

Frontiers in Aging Neuroscience, Journal Year: 2022, Volume and Issue: 14

Published: Aug. 8, 2022

The proportion of the world's elderly population continues to rise, and treatment improvement neurodegenerative diseases have become issue public health importance as people live longer many countries aging populations. This systematic review aims discuss effects dance movement therapy (DMT) on motor function, cognitive deficit, mood, quality life in with diseases, such Parkinson's disease (PD), mild impairment (MCI), Alzheimer's (AD).Two reviewers independently conducted search Cochrane library, PubMed database, Web Science Core Collection Physiotherapy Evidence database until February 1, 2022. Only analyses randomized controlled trials were included further analyzed.Thirty-three studies PD, 16 MCI, 4 AD obtained. found that DMT substantially improved global memory, executive function MCI. Compared non-dance group, remarkably general condition, balance, gait for individuals PD. evidence efficacy is insufficient, research needed.DMT can effectively improve deficits diseases. Positive mood ND patients are controversial require evidence. Future requires scientific design, large sample size, long-term comprehensive intervention, clear reporting standards.www.osf.io/wktez, identifier: 10.17605/OSF.IO/UYBKT.

Language: Английский

Cognitive impairment in people living with HIV: consensus recommendations for a new approach DOI Open Access
Sam Nightingale, Beau M. Ances, Paola Cinque

et al.

Nature Reviews Neurology, Journal Year: 2023, Volume and Issue: 19(7), P. 424 - 433

Published: June 13, 2023

Language: Английский

Citations

88
Overlooked cases of mild cognitive impairment: Implications to early Alzheimer’s disease DOI

Maamoon Mian,

Jihane Tahiri,

Ryan Eldin

et al.

Ageing Research Reviews, Journal Year: 2024, Volume and Issue: 98, P. 102335 - 102335

Published: May 12, 2024

Language: Английский

Citations

25
Depression and Cognitive Impairment—Extrahepatic Manifestations of NAFLD and NASH DOI Creative Commons
Martina Colognesi, Daniela Gabbia, Sara De Martin

et al.

Biomedicines, Journal Year: 2020, Volume and Issue: 8(7), P. 229 - 229

Published: July 21, 2020

Non-alcoholic fatty liver disease (NAFLD) and its complication non-alcoholic steatohepatitis (NASH) are important causes of worldwide. Recently, a significant association between these hepatic diseases different central nervous system (CNS) disorders has been observed in an increasing number patients. NAFLD-related CNS dysfunctions include cognitive impairment, hippocampal-dependent memory mood imbalances (in particular, depression anxiety). This review aims at summarizing the main correlations NAFLD development dysfunctions, focusing on studies investigating mechanism(s) involved this association. Growing evidences point cerebrovascular alteration, neuroinflammation, brain insulin resistance as NAFLD/NASH-related manifestations. Since pharmacological options available for management conditions still limited, further needed to unravel NAFLD/NASH their manifestations identify effective targets.

Language: Английский

Citations

79
Mild Cognitive Impairment: An Overview DOI Creative Commons
Biraj Bhattarai,

Hema Nagaraj

IntechOpen eBooks, Journal Year: 2022, Volume and Issue: unknown

Published: Oct. 6, 2022

Heterogeneity of symptoms within and among mild cognitive impairment (MCI) individuals often makes it challenging to document cases clinically. Number diagnostic criteria have been proposed in recent decades. MOCA MMSE are two tests useful for the assessment MCI, besides neuroimaging studies with MRI PET scan, provided promising results early diagnosis MCI. Lifestyle changes training found be more effective treatment

Language: Английский

Citations

56
A Scoping Review for Usage of Telerehabilitation among Older Adults with Mild Cognitive Impairment or Cognitive Frailty DOI Open Access
Nurul Hidayah Md Fadzil, Suzana Shahar, Roslee Rajikan

et al.

International Journal of Environmental Research and Public Health, Journal Year: 2022, Volume and Issue: 19(7), P. 4000 - 4000

Published: March 28, 2022

Older adults are vulnerable towards cognitive frailty that can lead to adverse health outcomes and telerehabilitation appears be a potential platform reverse among older adults. The aim of this coping review is identify the usage its common delivery with mild impairment (MCI) or (CF). Articles published from January 2015 until October 2020 were selected. Out 1738 articles retrieved, six studies identified. Two randomized controlled trials, one was pilot study three qualitative studies. outcome suggests may improve quality life participants as well it useful supportive digital for care. Some types technologies commonly used smartphones telephones internet, television-based assistive integrated technology, mobile application videoconference. Telerehabilitation utilization in managing still limited more research required evaluate feasibility acceptability. Although implemented MCI CF, some social support adherence effectiveness telerehabilitation. Future should focus on evaluation acceptance participants’ existing knowledge achieve target.

Language: Английский

Citations

47
The relationship between midlife dyslipidemia and lifetime incidence of dementia: A systematic review and meta‐analysis of cohort studies DOI Creative Commons
Jason Wee, Sara Sukudom, Saiuj Bhat

et al.

Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring, Journal Year: 2023, Volume and Issue: 15(1)

Published: Jan. 1, 2023

Abstract Introduction We conducted a systematic review and meta‐analysis to the relationship between midlife dyslipidemia lifetime incident dementia. Methods The databases Medline, Embase, Scopus, Web of Science, Cochrane were searched from inception February 20, 2022. Longitudinal studies examining lipid levels on dementia, dementia subtypes, and/or cognitive impairment pooled using inverse‐variance weighted random‐effects meta‐analysis. Results Seventeen (1.2 million participants) included. Midlife hypercholesterolemia was associated with increased incidence mild (effect size [ES] = 2.01; 95% confidence interval [CI] 1.19 2.84; I 2 0.0%) all‐cause (ES 1.14; CI: 1.07 1.21; 0.0%). Each 1 mmol/L increase in low‐density lipoprotein an 8% 1.08, 1.03 0.3%) Discussion is risk later life.

Language: Английский

Citations

43
Retinal imaging and Alzheimer’s disease: a future powered by Artificial Intelligence DOI
Hamidreza Ashayeri, Ali Jafarizadeh, Milad Yousefi

et al.

Graefe s Archive for Clinical and Experimental Ophthalmology, Journal Year: 2024, Volume and Issue: 262(8), P. 2389 - 2401

Published: Feb. 15, 2024

Language: Английский

Citations

18
Role of Cognitive Frailty in Older Adults With Cardiovascular Disease DOI Creative Commons

Naila Ijaz,

Yasser Jamil, Charles H. Brown

et al.

Journal of the American Heart Association, Journal Year: 2024, Volume and Issue: 13(4)

Published: Feb. 14, 2024

As the older adult population expands, an increasing number of patients affected by geriatric syndromes are seen cardiovascular clinicians. One such syndrome that has been associated with poor outcomes is cognitive frailty: simultaneous presence impairment, without evidence dementia, and physical frailty, which results in decreased reserve. Driven common pathophysiologic underpinnings (eg, inflammation neurohormonal dysregulation), disease, frailty also share following risk factors: hypertension, diabetes, obesity, sedentary behavior, tobacco use. Cardiovascular disease onset progression may be reversible early stages, making it essential for clinicians to diagnose condition a timely manner prescribe appropriate interventions. Additional research required elucidate mechanisms underlying development establish preventive therapeutic strategies address needs at ultimately facilitate targeted intervention studies.

Language: Английский

Citations

17
From Liver to Brain: How MAFLD/MASLD Impacts Cognitive Function DOI Open Access
David Medina‐Julio, Mariana M. Ramírez-Mejía, Jacqueline Córdova‐Gallardo

et al.

Medical Science Monitor, Journal Year: 2024, Volume and Issue: 30

Published: Jan. 16, 2024

Metabolic dysfunction-associated fatty liver disease or metabolic steatotic (MAFLD/MASLD), is a common chronic condition affecting substantial global population. Beyond its primary impact on function, MAFLD/MASLD associated with myriad of extrahepatic manifestations, including cognitive impairment. The scope impairment within the realm matter escalating concern. Positioned as an intermediate stage between normal aging process and onset dementia, manifests challenge this condition. Insights from studies underscore presence compromised executive function decline in capabilities among individuals identified being at risk progressing to fibrosis. Importantly, transcends mere association factors, delving deep into intricate pathophysiology characterizing MAFLD/MASLD. multifaceted nature context underlined by spectrum prominently featuring insulin resistance, lipotoxicity, systemic inflammation pivotal contributors. These factors interplay landscape MAFLD/MASLD, fostering nuanced understanding links hepatic health function. By synthesizing available evidence, exploring potential mechanisms, assessing clinical implications, overarching aim review contribute more complete

Language: Английский

Citations

16
Gut microbiome predicts cognitive function and depressive symptoms in late life DOI Creative Commons
Antonija Kolobaric, Carmen Andreescu, Eldin Jašarević

et al.

Molecular Psychiatry, Journal Year: 2024, Volume and Issue: 29(10), P. 3064 - 3075

Published: April 25, 2024

Depression in older adults with cognitive impairment increases progression to dementia. Microbiota is associated current mood and cognition, but the extent which it predicts future symptoms unknown. In this work, we identified microbial features that reflect predict depressive symptoms. Clinical assessments stool samples were collected from 268 participants varying Seventy underwent 2-year follow-up. Microbial community diversity, structure, composition assessed using high-resolution 16 S rRNA marker gene sequencing. We implemented linear regression characterize relationship between microbiome composition, impairment, leveraged elastic net discover or function Greater diversity lower cognition whole sample, greater depression not on antidepressants. Poor relative abundance of Bifidobacterium, while GABA degradation severity. Future decline function, Intestinibacter, glutamate degradation, higher baseline histamine synthesis. increase anxiety, diabetes, Bacteroidota, degradation. Our results suggest dysfunction are unique states an overall biological effect detectable through gut microbiota. The may present a noninvasive readout prognostic tool for psychiatric states.

Language: Английский

Citations

13